Sign in

Covid-19: Some outbound flyers may be able to get boosters early

The idea is one of several discussed by the government’s expert panel which is looking at several issues related to booster doses, including reducing the gap for all eligible people to about six months

Published on: May 5, 2022, 07:12:58 IST
By , Hindustan Times, New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

India may reconsider the nine-month gap between the second Covid-19 shot and the booster dose for those travelling overseas, especially to countries mandating that arriving travellers have been administered a third shot, people familiar with the matter said. This may be reduced to six months, they added.

According to health ministry data, at least 105.8 million people were eligible for the booster dose (those who had received both shots of the vaccine as on August 1, 2021) as on May 1, but only 28.3 million have taken one. (PTI)
According to health ministry data, at least 105.8 million people were eligible for the booster dose (those who had received both shots of the vaccine as on August 1, 2021) as on May 1, but only 28.3 million have taken one. (PTI)

The idea is one of several discussed by the government’s expert panel which is looking at several issues related to booster doses, including reducing the gap for all eligible people to about six months

Several people have made representations to the central government lately on reducing the gap as many countries have begun asking for a booster dose, creating hurdles for those intending to travel abroad for employment, education, business, or pleasure. In addition, some experts have said that reducing the gap from the current nine months would speed up the booster drive -- which is currently lagging. According to health ministry data, at least 105.8 million people were eligible for the booster dose (those who had received both shots of the vaccine as on August 1, 2021) as on May 1, but only 28.3 million have taken one. The government’s expert advisory panel, National Technical Advisory Group on Immunisation (NTAGI) is looking at the available evidence to make recommendations in this regard.

“ NTAGI is looking at data to see if it is good to reduce the gap from existing nine months. They might prioritise those who urgently need a booster for the purpose of travel as many countries have made it a requirement for travel. However, ultimate decision will be based on what the opinion is of experts on the technical panel,” said a senior government functionary aware of the matter, on condition of anonymity. The move also comes as vaccines are being wasted for lack of people to administer them to (each vial of Covishield for instance, vaccinates 10 people. Several studies have established the fact that antibody levels decline over time in the vaccinated persons, making a case for opening up of booster doses to widen the protection.India started booster shots among health care and frontline workers, and in the 60+ age group with comorbidities from January 10, this year. The eligibility was expanded to all adults from April 10.

NTAGI members met on Wednesday to discuss reducing the gap for booster shots, and expanding the vaccine drive to children below the age of 11 years. No final decision, however, was taken on both the matters, according to people familiar with the development. With the protection of vaccines against the pathogen falling over time, especially for new variants, experts are all for expanding timely boosting. “It has been seen that some of the vaccine derived protection is recovered by boosting,” said Anurag Agrawal, former director, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB).

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More